This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Sempio Foods Company. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Byung Serk Hurh: Innovator in Antioxidant Peptide Technology
Introduction
Byung Serk Hurh is a notable inventor based in Sejong, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of functional peptides with antioxidant properties. His work aims to address the limitations of existing antioxidant peptides, providing innovative solutions for cellular damage caused by oxidative stress.
Latest Patents
Hurh holds a patent for a peptide having antioxidant activity and a composition containing the same. This invention presents a functional peptide that exhibits excellent biocompatibility and significantly improved antioxidant activity compared to conventional glutathione (GSH) peptides. The peptide is designed to promote antioxidant activity and effectively repair biological tissue or cell damage caused by reactive oxygen species generated due to oxidative stress. This advancement has the potential to prevent and repair cell damage, making it a valuable asset in medical and therapeutic applications.
Career Highlights
Byung Serk Hurh is associated with Sempio Foods Company, where he applies his expertise in peptide technology. His innovative approach has garnered attention in the field, showcasing his commitment to advancing biotechnological solutions.
Collaborations
Hurh collaborates with esteemed colleagues, including Dae Hee Lee and Haet Nim Um, who contribute to his research and development efforts. Their combined expertise enhances the potential impact of their work in the industry.
Conclusion
Byung Serk Hurh's contributions to antioxidant peptide technology represent a significant advancement in the field of biotechnology. His innovative work not only addresses existing challenges but also opens new avenues for therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile